Cue Biopharma
89 hedge funds and large institutions have $229M invested in Cue Biopharma in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 31 increasing their positions, 33 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
8% less funds holding
Funds holding: 97 → 89 (-8)
57% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 14
76% less call options, than puts
Call options by funds: $732K | Put options by funds: $3.06M
Holders
89
Holding in Top 10
2
Calls
$732K
Puts
$3.06M
Top Buyers
| 1 | +$7.73M | |
| 2 | +$3.12M | |
| 3 | +$2.41M | |
| 4 |
SMH
Sanders Morris Harris
Houston,
Texas
|
+$1.98M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.34M |
Top Sellers
| 1 | -$5.66M | |
| 2 | -$4.27M | |
| 3 | -$3.75M | |
| 4 |
Millennium Management
New York
|
-$3.47M |
| 5 |
Morgan Stanley
New York
|
-$2.74M |